Annual Total Liabilities
$8.60 M
+$349.00 K+4.23%
March 31, 2024
Summary
- As of February 7, 2025, SNOA annual total liabilities is $8.60 million, with the most recent change of +$349.00 thousand (+4.23%) on March 31, 2024.
- During the last 3 years, SNOA annual total liabilities has fallen by -$1.02 million (-10.61%).
- SNOA annual total liabilities is now -28.60% below its all-time high of $12.05 million, reached on March 31, 2007.
Performance
SNOA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$8.80 M
+$465.00 K+5.58%
December 31, 2024
Summary
- As of February 7, 2025, SNOA quarterly total liabilities is $8.80 million, with the most recent change of +$465.00 thousand (+5.58%) on December 31, 2024.
- Over the past year, SNOA quarterly total liabilities has increased by +$872.00 thousand (+11.00%).
- SNOA quarterly total liabilities is now -36.67% below its all-time high of $13.89 million, reached on September 30, 2012.
Performance
SNOA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SNOA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.2% | +11.0% |
| 3 y3 years | -10.6% | +6.6% |
| 5 y5 years | +117.3% | +6.6% |
SNOA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.2% | +4.2% | -13.3% | +11.0% |
| 5 y | 5-year | -15.2% | +117.3% | -13.3% | +66.4% |
| alltime | all time | -28.6% | +1051.7% | -36.7% | +210.2% |
Sonoma Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $8.80 M(+5.6%) |
| Sep 2024 | - | $8.33 M(-4.2%) |
| Jun 2024 | - | $8.70 M(+1.1%) |
| Mar 2024 | $8.60 M(+4.2%) | $8.60 M(+8.5%) |
| Dec 2023 | - | $7.93 M(-0.4%) |
| Sep 2023 | - | $7.96 M(-8.0%) |
| Jun 2023 | - | $8.65 M(+4.8%) |
| Mar 2023 | $8.25 M(-18.7%) | $8.25 M(-1.4%) |
| Dec 2022 | - | $8.37 M(+5.4%) |
| Sep 2022 | - | $7.94 M(-13.7%) |
| Jun 2022 | - | $9.20 M(-9.4%) |
| Mar 2022 | $10.15 M(+5.4%) | $10.15 M(+24.1%) |
| Dec 2021 | - | $8.18 M(-2.3%) |
| Sep 2021 | - | $8.37 M(-11.9%) |
| Jun 2021 | - | $9.50 M(-1.3%) |
| Mar 2021 | $9.62 M(+7.7%) | $9.62 M(+62.7%) |
| Dec 2020 | - | $5.92 M(-10.1%) |
| Sep 2020 | - | $6.58 M(-9.1%) |
| Jun 2020 | - | $7.24 M(-19.0%) |
| Mar 2020 | $8.94 M(+125.7%) | $8.94 M(+69.0%) |
| Dec 2019 | - | $5.29 M(-10.0%) |
| Sep 2019 | - | $5.87 M(+8.5%) |
| Jun 2019 | - | $5.41 M(+36.8%) |
| Mar 2019 | $3.96 M(+2.0%) | $3.96 M(+6.9%) |
| Dec 2018 | - | $3.71 M(+4.0%) |
| Sep 2018 | - | $3.56 M(-11.0%) |
| Jun 2018 | - | $4.00 M(+3.2%) |
| Mar 2018 | $3.88 M(-3.7%) | $3.88 M(-5.3%) |
| Dec 2017 | - | $4.10 M(+2.7%) |
| Sep 2017 | - | $3.99 M(+4.7%) |
| Jun 2017 | - | $3.81 M(-5.3%) |
| Mar 2017 | $4.03 M(+10.0%) | $4.03 M(-13.3%) |
| Dec 2016 | - | $4.64 M(+45.0%) |
| Sep 2016 | - | $3.20 M(-10.3%) |
| Jun 2016 | - | $3.57 M(-2.5%) |
| Mar 2016 | $3.66 M(+22.3%) | $3.66 M(+22.9%) |
| Dec 2015 | - | $2.98 M(+5.1%) |
| Sep 2015 | - | $2.84 M(-7.6%) |
| Jun 2015 | - | $3.07 M(+2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | $2.99 M(-65.7%) | $2.99 M(-25.3%) |
| Dec 2014 | - | $4.01 M(-20.3%) |
| Sep 2014 | - | $5.02 M(-22.4%) |
| Jun 2014 | - | $6.47 M(-25.8%) |
| Mar 2014 | $8.73 M(+2.9%) | $8.73 M(+35.4%) |
| Dec 2013 | - | $6.45 M(-12.1%) |
| Sep 2013 | - | $7.33 M(-7.9%) |
| Jun 2013 | - | $7.96 M(-6.1%) |
| Mar 2013 | $8.48 M(-2.5%) | $8.48 M(-2.5%) |
| Dec 2012 | - | $8.70 M(-37.4%) |
| Sep 2012 | - | $13.89 M(+48.6%) |
| Jun 2012 | - | $9.35 M(+7.4%) |
| Mar 2012 | $8.71 M(+25.0%) | $8.71 M(-1.3%) |
| Dec 2011 | - | $8.82 M(+11.6%) |
| Sep 2011 | - | $7.90 M(-10.5%) |
| Jun 2011 | - | $8.82 M(+26.7%) |
| Mar 2011 | $6.96 M(+119.4%) | $6.96 M(+22.3%) |
| Dec 2010 | - | $5.69 M(+19.7%) |
| Sep 2010 | - | $4.76 M(-1.5%) |
| Jun 2010 | - | $4.83 M(+52.2%) |
| Mar 2010 | $3.17 M(-0.2%) | $3.17 M(+5.3%) |
| Dec 2009 | - | $3.01 M(-20.3%) |
| Sep 2009 | - | $3.78 M(-23.4%) |
| Jun 2009 | - | $4.93 M(+55.3%) |
| Mar 2009 | $3.18 M(-61.2%) | $3.18 M(-20.4%) |
| Dec 2008 | - | $3.99 M(-15.1%) |
| Sep 2008 | - | $4.70 M(-13.3%) |
| Jun 2008 | - | $5.43 M(-33.7%) |
| Mar 2008 | $8.18 M(-32.1%) | $8.18 M(+23.8%) |
| Dec 2007 | - | $6.61 M(-0.4%) |
| Sep 2007 | - | $6.64 M(-39.3%) |
| Jun 2007 | - | $10.94 M(-9.2%) |
| Mar 2007 | $12.05 M(+125.2%) | $12.05 M(+1.8%) |
| Dec 2006 | - | $11.83 M(+30.3%) |
| Sep 2006 | - | $9.08 M(+69.7%) |
| Mar 2006 | $5.35 M(+12.9%) | $5.35 M(+12.9%) |
| Mar 2005 | $4.74 M(+355.6%) | $4.74 M |
| Mar 2003 | $1.04 M(+39.2%) | - |
| Mar 2002 | $747.00 K | - |
FAQ
- What is Sonoma Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual total liabilities year-on-year change?
- What is Sonoma Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly total liabilities year-on-year change?
What is Sonoma Pharmaceuticals annual total liabilities?
The current annual total liabilities of SNOA is $8.60 M
What is the all time high annual total liabilities for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual total liabilities is $12.05 M
What is Sonoma Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, SNOA annual total liabilities has changed by +$349.00 K (+4.23%)
What is Sonoma Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of SNOA is $8.80 M
What is the all time high quarterly total liabilities for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly total liabilities is $13.89 M
What is Sonoma Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, SNOA quarterly total liabilities has changed by +$872.00 K (+11.00%)